These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17161975)

  • 1. Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis.
    Namura K; Hasegawa G; Egawa M; Matsumoto T; Kobayashi R; Yano T; Katoh N; Kishimoto S; Ohta M; Obayashi H; Ose H; Fukui M; Nakamura N; Yoshikawa T
    Clin Immunol; 2007 Feb; 122(2):181-6. PubMed ID: 17161975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
    Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
    J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis.
    Raap U; Werfel T; Goltz C; Deneka N; Langer K; Bruder M; Kapp A; Schmid-Ott G; Wedi B
    Allergy; 2006 Dec; 61(12):1416-8. PubMed ID: 17073871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
    Hon KL; Lam MC; Wong KY; Leung TF; Ng PC
    Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
    Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
    Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor gene polymorphisms and serum levels in Chinese atopic dermatitis patients.
    Ma L; Gao XH; Zhao LP; Di ZH; Mchepange UO; Zhang L; Chen HD; Wei HC
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1277-81. PubMed ID: 19522715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood atopic dermatitis-Brain-derived neurotrophic factor correlates with serum eosinophil cationic protein and disease severity.
    Fölster-Holst R; Papakonstantinou E; Rüdrich U; Buchner M; Pite H; Gehring M; Kapp A; Weidinger S; Raap U
    Allergy; 2016 Jul; 71(7):1062-5. PubMed ID: 27087278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.
    Jenerowicz D; Czarnecka-Operacz M; Silny W
    Acta Dermatovenerol Croat; 2006; 14(2):73-80. PubMed ID: 16859611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children.
    La Grutta S; Richiusa P; Pizzolanti G; Mattina A; Pajno GB; Citarrella R; Passalacqua G; Giordano C
    Allergy; 2005 Mar; 60(3):391-5. PubMed ID: 15679728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
    Ezzat MH; Sallam MA; Shaheen KY
    Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence.
    Lee BC; Choi IG; Kim YK; Ham BJ; Yang BH; Roh S; Choi J; Lee JS; Oh DY; Chai YG
    Alcohol; 2009 Jun; 43(4):265-9. PubMed ID: 19560628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
    Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
    J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral levels of BDNF and NGF in primary headaches.
    Blandini F; Rinaldi L; Tassorelli C; Sances G; Motta M; Samuele A; Fancellu R; Nappi G; Leon A
    Cephalalgia; 2006 Feb; 26(2):136-42. PubMed ID: 16426267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nerve growth factor and brain-derived neurotrophic factor: a possible etiopathogenic role in sensorineural hearing loss. Preliminary data].
    Salvinelli F; Antonelli A; Stampachiacchiere B; Bianchi di Castelbianco F; Casale M; D'Ascanio L; Greco F; Aloe L
    Ann Ist Super Sanita; 2003; 39(2):189-94. PubMed ID: 14587217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.